A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/22/2011	US20110313035 Polymorphs of darunavir
12/22/2011	US20110313034 Neuroactive plant extract from hypericum polyanthemum
12/22/2011	US20110313033 Ophthalmic uses of s1p receptor modulators
12/22/2011	US20110313032 Competitive inhibitors of type ii dehydroquinase enzyme
12/22/2011	US20110313031 Olioodeoxynucleotide and its use to induce an immune response
12/22/2011	US20110313030 Pkr activation via hybridization chain reaction
12/22/2011	US20110313029 Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
12/22/2011	US20110313026 Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
12/22/2011	US20110313025 Methods and compositions involving mirna and mirna inhibitor molecules
12/22/2011	US20110313023 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF
12/22/2011	US20110313022 Compositions and Methods for Diminishing Viral Infection and Inflammation Associated with Viral Infection
12/22/2011	US20110313021 Method to rapidly identify critical p53 target genes that can be utilized for therapeutic intervention
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313019 Oligomeric compounds and methods
12/22/2011	US20110313018 Cancer related gene, lgn/gpsm2
12/22/2011	US20110313017 Snalp formulations containing polyoxazoline-dialkyloxypropyl conjugates
12/22/2011	US20110313016 Treatment of Intestinal Conditions
12/22/2011	US20110313014 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
12/22/2011	US20110313013 Triple reuptake inhibitors and methods of their use
12/22/2011	US20110313012 Amino Acid Compounds
12/22/2011	US20110313011 Amino Acid Compounds
12/22/2011	US20110313010 Combination of local temozolomide with local bcnu
12/22/2011	US20110313009 Nsaid dose unit formulations with h2-receptor antagonists and methods of use
12/22/2011	US20110313008 Pentafluorosulpholane-containing antidiabetic compounds
12/22/2011	US20110313007 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
12/22/2011	US20110313006 PHARMACEUTICAL COMPOSITION OF LEVAMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND β RECEPTOR BLOCKING AGENT, AND USE THEREOF
12/22/2011	US20110313005 Topically applicable pharmaceutical preparation
12/22/2011	US20110313004 Deuterated pyridinones
12/22/2011	US20110313003 Gpr120 receptor agonists and uses thereof
12/22/2011	US20110313002 Tricyclic compounds
12/22/2011	US20110313001 Triazole derivatives for treatment of alzheimer's disease
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312998 Methods of Making and Using Stable Pharmaceutical Compositions Comprising Ketotifen and Naphazoline
12/22/2011	US20110312997 Inhibition of WDR5 Interaction with Its Binding Partners
12/22/2011	US20110312996 Novel inhibitors of hepatitis c virus replication
12/22/2011	US20110312995 Bridged and fused heterocyclic antidiabetic compounds
12/22/2011	US20110312994 Biphenyl derivatives
12/22/2011	US20110312993 Amido-tropane derivatives
12/22/2011	US20110312992 Inhibitors of C-Kit and Uses Thereof
12/22/2011	US20110312991 Activated blood coagulation factor inhibitor
12/22/2011	US20110312990 Diamine Derivatives
12/22/2011	US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
12/22/2011	US20110312988 Sns-595 and methods of using the same
12/22/2011	US20110312987 Salt of naphthyridine carboxylic acid derivative
12/22/2011	US20110312986 Composition and Method for Treating Overactive Bladder
12/22/2011	US20110312985 Naringenin complexes and methods of use thereof
12/22/2011	US20110312984 Stat3 inhibitors
12/22/2011	US20110312983 Deuterium-enriched alogliptin
12/22/2011	US20110312982 Cancer Treatment Method
12/22/2011	US20110312981 Predictive marker for egfr inhibitor treatment
12/22/2011	US20110312980 Small-molecule Hsp90 Inhibitors
12/22/2011	US20110312979 Fused pyrrole derivatives as pi3k inhibitors
12/22/2011	US20110312978 Pde1 inhibitors for ophthalmic disorders
12/22/2011	US20110312977 Process for the preparation of voriconazole
12/22/2011	US20110312976 Novel isoindolin-1-one derivative
12/22/2011	US20110312975 Certain chemical entities, compositions and methods
12/22/2011	US20110312974 Heteroaryl antagonists of prostaglandin d2 receptors
12/22/2011	US20110312973 Solid compositions
12/22/2011	US20110312972 Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof
12/22/2011	US20110312971 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/22/2011	US20110312970 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/22/2011	US20110312969 Compounds for treating cancer
12/22/2011	US20110312968 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors
12/22/2011	US20110312967 Bridged and fused antidiabetic compounds
12/22/2011	US20110312965 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
12/22/2011	US20110312964 Cysteine protease inhibitors
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312962 Novel 2-morpholino-3-amido-pyridine derivatives and their medical use
12/22/2011	US20110312961 2,5-Disubstituted Morpholine Orexin REceptor Antagonists
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312959 Derivatives of Azaindoles as Inhibitors of Protein Kinases ABL and SRC
12/22/2011	US20110312958 Modulators of atp-binding cassette transporters
12/22/2011	US20110312957 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
12/22/2011	US20110312956 ARYLINDENOPYRIMIDINES WITH REDUCED hERG CHANNEL BINDING
12/22/2011	US20110312955 Triazine compounds as pi3 kinase and mtor inhibitors
12/22/2011	US20110312954 Mineralocorticoid receptor antagonist and methods of use
12/22/2011	US20110312952 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/22/2011	US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof
12/22/2011	US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011	US20110312949 Pharmaceutical use of substituted amides
12/22/2011	US20110312948 Crystalline Forms of the Tri-Mesylate Salt of Perphenazine-Gaba and Process of Producing the Same
12/22/2011	US20110312947 Method of improving ß-adrenergic receptor function
12/22/2011	US20110312946 Combination therapy for the treatment of diabetes
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312943 Aurora kinase inhibitors for inhibiting mitotic progression
12/22/2011	US20110312942 Aurora kinase inhibitors for inhibiting mitotic progression
12/22/2011	US20110312941 1,4-disubstituted piperidines as vasopressin receptor via antagonists
12/22/2011	US20110312940 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (p13-kinases) inhibitor
12/22/2011	US20110312939 New chemical compounds
12/22/2011	US20110312938 Pyrrolopyridine Carboxylic Acid Derivatives
12/22/2011	US20110312937 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312934 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
12/22/2011	US20110312933 Oxyindole derivatives with motilin receptor agonistic activity
12/22/2011	US20110312932 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor
12/22/2011	US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/22/2011	US20110312930 Aryl compounds with aminoalkyl substituents and their use
12/22/2011	US20110312929 Treatment of vaginal atrophy in women with cardiovascular pathology risk

1 ... 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 ... 7860